August 20, 2026
Sanity Group
Organigram Global: Sanity Group integrated Into Global Corporate Structure
Press & Media Hub
Media Kit
Sanity Group's digital media kit includes: Detailed information about the company, factsheets, quotes and portraits.
Sanity Group & Brand Logos
The logo collection inclueds the standard Sanity Group logo as well as our brand logos.
Press Photos
Sanity Group's press images (high and web resolution) folder includes: Imagery of our management team.
April 16, 2026
Sanity Group
Organigram Global and Sanity Group Announce Successful Closing of Acquisition
April 1, 2026
Sanity Group
Evaluation Report on Second Anniversary of German Cannabis Act: Sanity Group Calls for Evidence-Based Regulation
March 23, 2026
Sanity Group
Sanity Group and Curaleaf Laboratories Announce Partnership to Advance Medical Cannabis Innovation in the UK
February 18, 2026
Sanity Group
Sanity Group Becomes Part of Canadian Cannabis Market Leader Organigram Global to Drive International Growth
About Sanity Group
At Sanity Group, we pursue a clear goal: Unlocking the full health potential of cannabinoids
The company was founded in Berlin in 2018 by Finn Hänsel and Fabian Friede and has been part of Organigram Global since 2026. As a health and life science company, Sanity Group aims to improve people’s quality of life by harnessing the potential of cannabinoids and the endocannabinoid system.
Its focus is on medical cannabis products, research on finished medicinal products and cannabinoid-based consumer goods.
Its focus is on medical cannabis products, research on finished medicinal products and cannabinoid-based consumer goods.
“It’s important to understand the full potential of the plant – that’s what we’re working for, to bring cannabis to the center of society.”
Finn Age Hänsel
Founder Sanity Group and President Rest of World und Chief Strategy Officer Organigram Global
Our Brands
An overview of our brands in medical cannabis, scientific pilot projects on adult-use cannabis and CBD products.
ZOIKS aims to improve patient care with high-quality medicinal cannabis through particularly affordable medicines.
avaay Medical supplies patients with high-quality cannabis medicines - for a individualized therapy with natural products.
Vayamed is a fully licensed pharmaceutical company that distributes medical cannabis medicines to pharmacies and clinical facilities - focusing on the supply to patients with statutory health insurance.
Grashaus Projects is an official scientific pilot project for adult-use cannabis in Switzerland, investigating the effects of the legal sale of THC-containing products on the consumption behaviour of study participants.
vaay positions itself as the "wellbeing brand" of Sanity Group, focusing on CBD products in the fields of cosmetics, dietary supplements, and lifestyle.
